O'Brien Medical, LLC
Introducing the ETF128, an innovative instrument tailored for the neurodiagnostic market.
Introducing the ETF128, an innovative instrument tailored for the neurodiagnostic market.
O'Brien Medical is a company founded by Todd O’Brien in 1999, specializing in the development of medical devices. Their latest innovation, the ETF128, is a groundbreaking instrument tailored for the neurodiagnostic market. After a comprehensive five-year development and testing phase, the ETF128 is now available for this market, marking a significant milestone for the company. This innovation is poised to become the cornerstone of O'Brien Medical's offerings in the rapidly expanding neurodiagnostic field. The company's last investment of $10.94K came in the form of a grant from the Maine Technology Institute on December 12, 2017. With its focus on cutting-edge medical technology and successful track record, O'Brien Medical presents an exciting prospect for venture capitalists looking to invest in the healthcare and medical device sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $10.94K | 1 |
|
12 Dec 2017 |
| Grant | $2.40K | 1 |
|
05 Jul 2017 |
| Grant | $5.50K | 1 |
|
04 Feb 2015 |
| Debt Financing | $76.17K | 1 |
|
05 Nov 2013 |
| Grant | $8.40K | 1 |
|
09 Aug 2012 |
No recent news or press coverage available for O'Brien Medical, LLC.
We care about your data, and we'd love to use cookies make your experience better.